Beconase Articles
Rigel shares hit by R112's Ph II failure
12 December 2005
FDA gives Enteron's GVDH drug orphan status for new indication
28 September 2001
GW & W-L Dissolve OTC Joint Venture
5 August 1998
FDA And GW Put Beconase OTC Switch On Hold
11 September 1997
Glaxo Wellcome 1996 Product Performance
17 March 1997
Glaxo Wellcome Sells OTC Business To Warner-Lambert
8 January 1996
Competition and Acquisition Pressure Hits Glaxo
19 September 1994
WARNER WELLCOME JV SETS SIGHTS ON TOP SPOT
6 June 1994
UK INDUSTRY REPORT ON "BRIBERY" CHARGES
21 March 1994
GLAXO SEES 25% INTERIM TRADING PROFIT RISE
21 February 1994
OTC BECONASE TO BECOME AVAILABLE
14 February 1994
WORLD RESPIRATORY PRODUCTS MARKET
1 March 1993
Showing 1-13 of 13 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
